News
Does Immune12 contain any toxicity?
Scientific analyses of humans and lab rats show that Immune12 is non-toxic with no detected adverse effects. Our proprietary process gives us the ability to successfully
How is Immune12 administered during trials?
Immune12 is taken orally, best if mixed with fruit juice or a non-alcoholic beverage. It can also be administered through a feeding tube or sipped through
Suppression of Human Multiple Myeloma Cell Growth by TBL-12 in Combination with low doses of Velcade:
Multiple myeloma (MM) is characterized by the latent accumulation of plasma cells in the bone marrow. As the side effects due to drugs that are currently in use are largely complex, targeting MM with natural agents in combination with FDA approved drugs seems to be a novel approach to overcome the side effects. Methods: In this study we tested the efficacy of proteasome inhibitor Velcade (Bortezomib) in combination with TBL-12, (an extract from Sea Cucumber, Unicorn Pacific Corporation) in human myeloma cells that are IL-6- dependent and-independent.
Sea cucumber extract TBL‐12 inhibits prostate cancer
Prostate cancer is a significant health concern globally. Researchers are continuously seeking effective treatments to combat its growth and spread. In this study, the authors investigated the potential of a sea cucumber extract called TBL-12 in inhibiting the progression of prostate cancer.
The researchers conducted experiments using human prostate cancer cells in laboratory settings. They treated these cells with TBL-12 and observed its effects on various aspects of cancer progression, including cell proliferation (growth), migration (movement), and invasion (spread).
Effect of TBL-12 on Proliferation, Migration, Invasion, and Apoptosis of Gastric Cancer Cell HGC-27
Gastric cancer is one of the most common gastrointestinal tumors. In China, gastric cancer ranks the top three of morbidity and mortality of malignant tumors, and
exhibits a rising trend over the past 30 years. The percentage of gastric cancer in
China is high among the world. Nowadays, the treatment of gastric cancer mainly relies on surgical resection followed by adjuvant chemotherapy and radiotherapy. However, this treatment did not show satisfactory results. Therefore, the search for safe and effective anti-gastric cancer drugs is of prime importance.
ONCO: Marine-Derived Therapeutics for the Management of Glioblastoma: A Case Series and Comprehensive Review of the Literature
Glioblastoma is a fatal brain tumor, with recurrence and eventual mortality inevitable despite the current standard of care treatments. The identification of novel therapies capable of extending survival is therefore imperative. In this case series, we describe two cases in
which marine nutraceuticals were used in the management of glioblastoma and conferred a survival benefit exceeding the currently recognized median survival time of standard of care treatment.
In the subsequent literature review, we describe the mechanisms underlying the anticancer and immunogenic properties of marine nutraceuticals, which may contribute to their demonstrated
therapeutic benefit.